Targeting substance P and relaxin: A future combination therapy approach for heart failure?

Int J Cardiol. 2016 Feb 1:204:154-5. doi: 10.1016/j.ijcard.2015.11.157. Epub 2015 Nov 23.
No abstract available

Publication types

  • Letter
  • Research Support, Non-U.S. Gov't
  • Comment

MeSH terms

  • Animals
  • Heart / physiology*
  • Heart Failure / physiopathology*
  • Humans
  • Substance P / physiology*
  • Ventricular Remodeling / physiology*

Substances

  • Substance P